|
1
|
Forouzanfar MH, Foreman KJ, Delossantos
AM, Lozano R, Lopez AD, Murray CJ and Naghavi M: Breast and
cervical cancer in 187 countries between 1980 and 2010: A
systematic analysis. Lancet. 378:1461–1484. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Depuydt CE, Thys S, Beert J, Jonckheere J,
Salembier G and Boqers JJ: Linear viral load increase of a single
HPV-type in women with multiple HPV infections predicts progression
to cervical cancer. Int J Cancer. 139:2021–2032. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang JT, Ding L, Jiang SW, Hao J, Zhao WM,
Zhou Q, Yang ZK and Zhang L: Folate deficiency and aberrant
expression of DNA methyltransferase 1 were associated with cervical
cancerization. Curr Pharm Des. 20:1639–1646. PubMed/NCBI
|
|
4
|
Blount BC, Mack MM, Wehr CM, MacGregor JT,
Hiatt RA, Wang G, Wickramasinghe SN, Everson RB and Ames BN: Folate
deficiency causes uracil misincorporation into human DNA and
chromosome breakage: Implications for cancer and neuronal damage.
Proc Natl Acad Sci U S A. 94:pp. 3290–3295. 1997; View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Duthie SJ: Folic acid deficiency and
cancer: Mechanisms of DNA instability. Br Med Bull. 55:578–592.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Flatley JE, Sarqent A, Kitchener HC,
Russell JM and Powers HJ: Tumour suppressor gene methylation and
cervical cell folate concentration are determinants of high-risk
human papillomavirus persistence: A nested case control study. BMC
Cancer. 14:8032014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kobayashi LC, Limburg H, Miao Q, Woolcott
C, Bedard LL, Massey TE and Aronson KJ: Folate intake, alcohol
consumption and the methyl enetetrahydrofolate reductase (MTHFR)
C677T gene polymorphism: influence on prostate cancer risk and
interactions. Front Oncol. 2:1002012.PubMed/NCBI
|
|
8
|
Choi SW and Mason JB: Folate status:
Effects on pathways of colorectal carcinogenesis. J Nutr. 132(suppl
8): 2413S–2418S. 2002.PubMed/NCBI
|
|
9
|
Kim YI: Folate and carcinogenesis:
Evidence, mechanisms and implications. J Nutr Biochem. 10:66–88.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Flatley JE, McNeir K, Balasubramani L,
Tidy J, Stuart EL, Young TA and Powers HJ: Folate status and
aberrant DNA methylation are associated with HPV infection and
cervical pathogenesis. Cancer Epidemiol Biomarkers Prev.
18:2782–2789. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun XS, Ding L, Chen F, Wu T and Wang J:
Effects of folate deficiency with HPVl6 infection on cervix
cancerization. Zhonghua Liu Xing Bing Xue Za Zhi. 35:437–41.
2014.PubMed/NCBI
|
|
12
|
Kanai Y and Hirohashi S: Alterations of
DNA methylation associated with abnormalities of DNA
methyltransferases in human cancers during transition from a
precancerous to a malignant state. Carcinogenesis. 28:2434–42.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jones PA: DNA methylation errors and
cancer. Cancer Res. 56:2463–2467. 1996.PubMed/NCBI
|
|
14
|
Zhang A, Månér S, Betz R, Angström T,
Stendahl U, Bergman F, Zetterberg A and Wallin KL: Genetic
alterations in cervical carcinomas: Frequent low-level
amplifications of oncogenes are associated with human
papillomavirus infection. Int J Cancer. 101:427–433. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kulis M and Esteller M: DNA methylation
and cancer. Adv Genet. 70:27–56. 2010.PubMed/NCBI
|
|
16
|
Abouzeid HE, Kassem AM, Abdel Wahab AH,
El-mezayen HA, Sharad HA and Abdel Rahman S: Promoter
hypermethylation of RASSF1A, MGMT and HIC-1 genes in benign and
malignant colorectal tumors. Tumour Biol. 32:845–852. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Su Y, Wang X, Li J, Xu J and Xu L: The
clinicopathological significance and drug target potential of FHIT
in breast cancer, a meta-analysis and literature review. Drug Des
Devel Ther. 9:5439–5445. 2015.PubMed/NCBI
|
|
18
|
Al-Temaimi RA, Jacob S, Al-Ali W, Thomas
DA and Al-Mulla F: Reduced FHIT expression is associated with
mismatch repair deficient and high CpG island methylator phenotype
colorectal cancer. J Histochem Cytochem. 61:627–638. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Herzog CR, Crist KA, Sabourin CL, Kelloff
GJ, Boone CW, Stoner GD and You M: Chromosome 3p tumor suppressor
gene alterations in cervical carcinomas. Mol Careinog. 30:159–168.
2001. View
Article : Google Scholar
|
|
20
|
Liu XZ, Nan J, Li J, Li Y, Ding L and Wang
JT: Interaction between fragile histidine triad methylation,
protein expression and human papillomavirus 16 infection in
cervical carcinogenesis. Zhonghua Liu Xing Bing Xue Za Zhi.
37:858–862. 2016.(In Chinese). PubMed/NCBI
|
|
21
|
Czarnecka KH, Miqdalska-Sek M, Domanska D,
Pastuszak-Lewandoska D, Dutkowska A, Kordiak J, Nawrot E,
Kiszlkiewicz J, Antczak A and Brzeziańska-Lasota E: FHIT promoter
methylation status, low protein and high mRNA levels in patients
with non-small cell lung cancer. Int J Oncol. 49:1175–1184.
2016.PubMed/NCBI
|
|
22
|
Wang JT, Gao ES, Cheng YY, Yan JW and Ding
L: Analysis on synergistic action between estrogen, progesterone
and human papillomaviruses in cervical cancer. Zhonghua Liu Xing
Bing Xue Za Zhi. 26:370–373. 2005.(In Chinese). PubMed/NCBI
|
|
23
|
Bai LX, Wang JT, Ding L, Jiang SW, Kang
HJ, Gao CF, Chen X, Chen C and Zhou Q: Folate deficiency and FHIT
hypermethlation and HPV 16 infection promote cervical
cancerization. Asian Pac J Cancer Prev. 15:9313–9317. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen X, Wang J, Bai L, Ding L, Bai L, Xu J
and Sun XS: Interaction between folate deficiency and aberrant
expression related to fragile histidine triad gene in the
Progression of cervical cancerization. Zhonghua Liu Xing Bing Xue
Za Zhi. 36:387–392. 2015.(In Chinese). PubMed/NCBI
|
|
25
|
Guzmán-Olea E, Bermúdez-Morales VH,
Peralta-Zaragoza O, Torres-Poveda K and Madrid-Marine V: Molecular
mechanism and potential targets for blocking hpv-induced lesion
development. J Oncol. 2012:2783122012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kyrqiou M, Mitra A and Moscicki AB: Does
the vaginal microbiota plays a role in the development of cervical
cancer? Trans Res. 179:168–182. 2017. View Article : Google Scholar
|
|
27
|
Piyathilake CJ, Henao OL, Macaluso M,
Cornwell PE, Melleth S, Heimburqer and Partridqe EE: Folate is
associated with the natural history of high-riskt human
papillomaviruses. Cancer Res. 64:1–8793. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin SY, Lee WR, Su YF, Hsu SP, Lin HC, Ho
PY, Hou TC, Chou YP, Kuo CT and Lee WS: Folic acid inhibits
endothelial cell proliferation through activating the cSrc/ERK
2/NF-jB/p53 pathway mediated by folic acid receptor. Angiogenesis.
15:671–683. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hansen MF, Greibe E, Skovbjerq S, Rohde S,
Kristensen AC, Jensen TR, Stentoft C, Kjær KH, Kronborq CS and
Martensen PM: Folic acid mediates activation of the pro-oncogene
STAT3 via the Folate Receptor alpha. Cell Signal. 27:1356–1368.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang RF, Ho YH, Lin HL, Wei JS and Liu
TZ: Folate deficiency induces a cell cycle-specific apoptosis in
HepG2 cells. J Nutr. 129:25–31. 1999.PubMed/NCBI
|
|
31
|
Hearnden V, Powers HJ, Elmoqassabi A, Lowe
R and Murdoch C: Methyl-donor depletion of head and neck cancer
cells in vitro establishes a less aggressivetumour cell phenotype.
Eur J Nutr. March 1–2017.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sozzi G, Pastorino U, Moiraghi L,
Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner
K, Pierotti MA, et al: Loss of FHIT function in lung cancer and
preinvasive bronchial lesions. Cancer Res. 58:5032–5037.
1998.PubMed/NCBI
|
|
33
|
Kwan KY and Wong CS: DNA methylation of
tumor suppressor protein-coding and non-coding genes in multiple
myeloma. Epigenomics. 7:985–1001. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
lliopoulos D, Guler G, Han SY, Johnston D,
Druck T, McCorkell KA, Palazzo J, McCue PA, Baffa R and Huebner K:
Fragile genes as biomarker: Epigenetic control of WWOX and FHIT in
lung, breast and bladder cancer. Oncogene. 24:1625–1633. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dhillon VS, Shahid M and Husain SA: CpG
methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in
Granulosa cell tumors (GCFs) of ovarian origin. Mol Cancer.
3:332004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Geng X, Pu W, Tan Y, Lu Z, Wang A, Tan L,
Chen S, Guo S, Wang J and Chen X: Quantitative assessment of the
diagnostic role of FHIT promoter methylation in non-small cell lung
cancer. Oncotarget. 8:6845–6856. 2017.PubMed/NCBI
|
|
37
|
Widschwendter A, Gattringer C, Ivarsson L,
Fiegl H, Schneitter A, Ramoni A, Müller HM, Wiedemair A, Jerabek S,
Müller-Holzner E, et al: Analysis of aberrant DNA methylation and
human papillomavirus DNA in cervicovaginal specimens to detect
invasive cervical cancer and its precursors. Clin Cancer Res.
10:3396–3400. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao Y, Guo C, Hu H, Zheng L, Ma J, Jiang
L, Zhao E and Li H: Folate intake, serum folate levels and
esophageal cancer risk: An overall and dose-response meta-analysis.
Oncotarget. 8:10458–10469. 2017.PubMed/NCBI
|
|
39
|
Kim YI: Folate and DNA methylation: A
mechanistic link between folate deficiency and colorectal cancer?
Cancer Epidemiol Biomarkers Prev. 13:511–519. 2004.PubMed/NCBI
|
|
40
|
Liu J, Chen D, Mao X and Yu B: Effects of
maternal folic acid supplementation on morphology and
apoptosis-related gene expression in jejunum of newborn
intrauterine growth retarded piglets. Arch Anim Nutr. 65:376–385.
2011. View Article : Google Scholar : PubMed/NCBI
|
